We are live on ! Find out more
TCM

Tao Capital Management Portfolio holdings

AUM $1.94B
1-Year Est. Return 48.68%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+48.68%
3 Year Est. Return
+314.16%
5 Year Est. Return
+264.79%
10 Year Est. Return
AUM
$1.94B
AUM Growth
+$1.82B
Cap. Flow
+$1.77B
Cap. Flow %
91.01%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
1
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
SPCX
SpaceX
SPCX
+$1.81B
2
TXG icon
10x Genomics
TXG
+$1.9M

Top Sells

Rank Stock Value
1
TWST icon
Twist Bioscience
TWST
+$22.8M
2
OUST icon
Ouster
OUST
+$15.5M
3
MASS icon
908 Devices
MASS
+$3.48M
4
WRBY icon
Warby Parker
WRBY
+$2.83M

Sector Composition

Rank Sector Weight
1 Industrials 93.75%
2 Healthcare 3.68%
3 Consumer Discretionary 2.57%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPCX
1
SpaceX
SPCX
$1.97T
$1.82B 93.75%
+10,644,340
New +$1.81B
TWST icon
2
Twist Bioscience
TWST
$8.27B
$49.3M 2.54%
478,815
-350,000
-42% -$22.8M
TSLA icon
3
Tesla
TSLA
$1.4T
$36.3M 1.87%
86,250
H icon
4
Hyatt Hotels
H
$15.7B
$13.6M 0.7%
70,000
MDGL icon
5
Madrigal Pharmaceuticals
MDGL
$12.4B
$11.3M 0.58%
21,000
TXG icon
6
10x Genomics
TXG
$8.02B
$10.9M 0.56%
283,469
+72,607
+34% +$1.9M
MASS icon
7
908 Devices
MASS
$410M
-568,981
Closed -$3.48M
OUST icon
8
Ouster
OUST
$2.56B
-845,316
Closed -$15.5M
WRBY icon
9
Warby Parker
WRBY
$2.97B
-134,473
Closed -$2.83M

Similar funds

Tao Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Tao Capital Management held 9 positions worth $1.94B, up 1,533% from $119M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tao Capital Management deployed $1.77B of net new capital in Q2 2026, opening 1 new position and adding to 1 existing holding. Its largest new stake was SpaceX: 10,644,340 shares worth $1.82B.

By sector, the portfolio is most concentrated in Industrials at 94% of assets, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Twist Bioscience, an estimated $22.8M trimmed.

  • Tao Capital Management's largest Q2 2026 buy was SpaceX: 10,644,340 shares worth $1.82B.
  • Tao Capital Management added most to 10x Genomics in Q2 2026, an estimated $1.9M increase.
  • Tao Capital Management's biggest Q2 2026 reduction was Twist Bioscience, cutting an estimated $22.8M.
  • Tao Capital Management fully exited Ouster in Q2 2026, selling an estimated $15.5M.
  • Tao Capital Management's ten largest holdings make up 100% of its $1.94B portfolio in Q2 2026.
  • Tao Capital Management opened 1 new position and closed 3 in Q2 2026.
  • Tao Capital Management's portfolio value rose 1,533% quarter-over-quarter to $1.94B.

Based on Tao Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.